Reference

PortadaPNAS11227DOI:10.1073/pnas.1506538112

Authors

Irene Garcia-Ferrer; Pedro Arêde; Josué G ómez-Blanco; Daniel Luque; Stephane Durrequoi; José R. Castón; Theodoros Goulas and F. Xavier Gomis-Rüth

Abstract

The survival of commensal bacteria requires them to evade host peptidases. Gram-negative bacteria from the human gut microbiome encode a relative of the human endopeptidase inhibitor, α2-macroglobulin (α2M). Escherichia coli α2M (ECAM) is a ∼ 180-kDa multidomain membrane-anchored pan-peptidase inhibitor, which is cleaved by host endopeptidases in an accessible bait region. Structural studies by electron microscopy and crystallography reveal that this cleavage causes major structural rearrangement of more than half the 13-domain structure from a native to a compact induced form. It also exposes a reactive thioester bond, which covalently traps the peptidase. Subsequently, peptidase-laden ECAM is shed from the membrane and may dimerize. Trapped peptidases are still active except against very large substrates, so inhibition potentially prevents damage of large cell envelope components, but not host digestion. Mechanistically, these results document a novel monomeric "snap trap."

Description

Las bacterias comensales que forman parte del microbioma humano deben sobrevivir en presencia de encimas digestivas provenientes del huésped y por lo tanto poseen mecanismos para combatir la acción nociva de dichas moléculas. Así, Escherichia coli codifica en su genoma una proteína homóloga a la α2-macroglobulina humana, un inhibidor de proteasas presente en el plasma sanguíneo. Este homólogo bacteriano, nombrado ECAM, es una proteína multidominio de 180 kDa que se encuentra en el periplasma bacteriano, anclado a la membrana interna de E.coli. Estudios funcionales han permitido probar su actividad como inhibidor de proteasas, así como relacionar su función con mecanismos de protección celular en E.coli. Además, se ha descrito un nuevo mecanismo de inhibición de proteasas por el cual esta proteína ejerce su función, nombrado mecanismo snap-trap, el cual podría ser utilizado por otras α2-macroglobulinas monoméricas. La caracterización estructural de ECAM, tanto por cristalografía de rayos X como por crio-microscopía electrónica, ha permitido identificar y describir elementos estructurales claves en este mecanismo.

 

GrupInvest

 

REFERENCIA DEL GRUPO INVESTIGADOR

Proteolysis lab es un grupo de investigación liderado por el Prof. F.X. Gomis-Rüth y establecido en el Instituto de Biología Molecular de Barcelona (IBMB-CSIC). El trabajo realizado en el grupo está centrado en el análisis de proteínas, principalmente peptidasas y sus inhibidores, tanto proteicos como de molécula pequeña. Para ello se emplean técnicas de biología molecular, caracterización biofísica de proteínas y cristalografía de rayos X, entre otras. El objetivo principal es entender la relación entre la estructura y la función de dichas proteínas, especialmente de aquellas relacionadas con mecanismos de virulencia bacteriana, con el fin de proporcionar información molecular necesaria para el diseño de nuevos fármacos.

Descárgate este artículo aquí.

Did you publish an interesting article recently?

Send it through our application form and we will contact you. Age limit: 32.

The selected articles will participate at the Award to the best article of young people of the SEBBM which will be given during SEBBM conference, that will take place at Spain (free registration, travel and accommodation).

More articles of the month

Sticholysin, Sphingomyelin, and Cholesterol: A Closer Look at a Tripartite Interaction

01-08-2019

Actinoporins are a group of soluble toxic proteins that bind to membranes containing sphingomyelin (SM) and oli- gomerize to form pores. Sticholysin II (StnII) is a member of the actinoporin...

Read more

Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour

01-07-2019

To satisfy its high energetic demand, the brain depends on the metabolic cooperation of various cell types. For example, astrocytic-derived lactate sustains memory consolidation by serving both as an oxidizable...

Read more

Glucose restriction promotes osteocyte specification by activating a PGC-1α-dependent transcriptional program

03-06-2019

Osteocytes, the most abundant of bone cells, differentiate while they remain buried within the bone matrix. This encasement limits their access to nutrients and likely affects their differentiation, a process...

Read more

ParB dynamics and the critical role of the CTD in DNA condensation unveiled by combined force-fluorescence measurements

01-05-2019

/Bacillus subtilis/ ParB forms multimeric networks involving non-specific DNA binding leading to DNA condensation. Previously, we found that an excess of the free C-terminal domain (CTD) of ParB impeded DNA...

Read more

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

01-04-2019

Although human epidermal growth factor receptor 2 (HER2)-targeted therapies have dramatically improved the clinical outcome of HER2-positive breast cancer patients, innate and acquired resistance remains an important clinical challenge. New...

Read more

p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton

01-03-2019

Planar cell polarity (PCP) and intercellular junctional complexes establish tissue structure and coordinated behaviors across epithelial sheets. In multiciliated ependymal cells, rotational and translational PCP coordinate cilia beating and direct...

Read more

β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9R239X mice

01-02-2019

Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In...

Read more

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

02-01-2019

Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons, a process that current therapeutic approaches cannot prevent. In PD, the typical pathological hallmark is the accumulation of...

Read more

Dynamic acetylation of cytosolic phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions

01-12-2018

Cytosolic phosphoenolpyruvate carboxykinase (PCK1) is considered a gluconeogenic enzyme; however, its metabolic functions and regulatory mechanisms beyond gluconeogenesis are poorly understood. Here, we describe that dynamic acetylation of PCK1 interconverts...

Read more

The Helicase PIF1 Facilitates Resection overSequences Prone to Forming G4 Structures

02-11-2018

DNA breaks are complex lesions that can be repaired either by non-homologous end joining (NHEJ) or by homologous recombination (HR). The decision between these two routes of DNA repair is...

Read more

Protector Members